Results 121 to 130 of about 3,747 (180)

METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: UPDATE. [PDF]

open access: yesArq Gastroenterol
Dezan MGF, Oliveira CP, Cotrim HP.
europepmc   +1 more source

ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. [PDF]

open access: yesArq Gastroenterol
Moreno MOA   +6 more
europepmc   +1 more source

Liver Cirrhosis Caused by Food-Borne Zoonotic Fasciola gigantica in Cattle in Bangladesh: Pathology and Immunological Orchestra. [PDF]

open access: yesImmun Inflamm Dis
Ali MH   +11 more
europepmc   +1 more source

GLP-1 AND CIRRHOSIS: EFFECTS ON MORTALITY AND LIVER-RELATED COMPLICATIONS. [PDF]

open access: yesArq Gastroenterol
Onwuzo CN   +5 more
europepmc   +1 more source

Relação entre fibrose hepática por doença hepática esteatótica associada à disfunção metabólica e aterosclerose subclínica

open access: yes
NTRODUÇÃO: A doença hepática esteatótica associada à disfunção metabólica (MASLD, do inglês, metabolic dysfunction–associated steatotic liver disease) é a principal causa de doença hepática no mundo e está intimamente relacionada às doenças ...
Araujo De Azeredo Coutinho, Daniele
core  

Fibrosis hepática congénita: complicaciones y manejo

open access: yesBoletín Médico del Hospital Infantil de México, 2014
Mario Perezpeña-Diazconti   +4 more
doaj   +1 more source

Polo-like kinase 1 regulates growth in juvenile Fasciola hepatica. [PDF]

open access: yesPLoS Pathog
McCusker P   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy